Bazelle J, Threlfall A and Whitley N (2018) Gastroprotectants in small animal veterinary practice – a review of the evidence. Part 1: cyto-protective drugs.Journal of Small Animal Practice 59, 587–602

Marks SL, Kook PH, Papich MG, Tolbert MK and Willard MD (2018) ACVIM consensus statement: support for rational administration of gastrointestinal protectants to dogs and cats.Journal of Veterinary Internal Medicine 32, 1823–1840

Hanson SM, Bostwick DR, Twedt DC and Smith MO (1997) Clinical evaluation of cimetidine, sucralfate, and misoprostol for prevention of gastrointestinal tract bleeding in dogs undergoing spinal surgery. A merican Journal of Veterinary Research 58, 1320–1323

Hill TL, Lascelles BDX and Blikslager AT (2018) Effect of sucralfate on gastric permeability in an ex vivo model of stress-related mucosal disease in dogs.Journal of Veterinary Internal Medicine 32, 670–678

Kukanich K and Kukanich B (2015) The effect of sucralfate tablets versus suspension on oral doxycycline absorption in dogs.Journal of Veterinary Pharmacology and Therapeutics 38, 169–173

Kukanich K, Kukanich B, Guess S et al. (2016) Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.Journal of Veterinary Internal Medicine 30, 108–115

Millersman G, Russell WL and Derendorf H (1986) Lack of clinically significant in vitro and in vivo interactions between ranitidine and sucralfate.Journal of Pharmaceutical Science 75, 995–998

Quimby J and Lappin M (2016) Evaluating sucralfate as a phosphate binder in normal cats and cats with chronic kidney disease. J ournal of the American Animal Hospital Association 52, 8–12

Steiner K, Bhring KU, Faro HP et al.(1982) Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals.Arzneimittel-Forschung 32, 512–518